Optimizing Blood‑Culture Yield in Patients with Persistent Fever Who Have Received Antibiotics

Impact of Prior Antibiotic Exposure

Prior antimicrobial therapy reduces bacterial recovery from blood cultures by 35–40 %. 1
The likelihood of a negative culture after antibiotic exposure rises to 35–40 % when broad‑spectrum agents such as meropenem are given before sampling, compared with ≈20 % in untreated patients with true infection. 2
Duration of culture negativity depends on (a) the organism’s antimicrobial susceptibility, (b) the dose and length of prior therapy, and (c) the nature of the drug (bactericidal agents have a greater suppressive effect). 3
Patients who have received only a few days of antibiotics may become culture‑positive after several antibiotic‑free days, whereas those treated with prolonged, high‑dose bactericidal regimens (e.g., meropenem) can remain culture‑negative for weeks. 1

In confirmed infective endocarditis, 95 % of pre‑antibiotic cultures isolate the causative organism and 91 % of cases have all drawn cultures positive. 1
Among emergency‑department patients with intra‑abdominal infections, blood cultures are positive in 12.7 % of cases; of these positives, 63.9 % represent true pathogens rather than contaminants. 4
True‑positive culture results that altered clinical management occurred in only 4 % of all patients in whom cultures were performed for intra‑abdominal infections. 4

Fastidious bacteria (e.g., Bartonella, Coxiella burnetii, Brucella, Legionella, Tropheryma whipplei) should be suspected when fever persists despite negative cultures. 6
In severely neutropenic patients, fungal infections remain a key possibility even under broad‑spectrum antibacterial therapy. 7
Inadequate microbiological techniques can contribute to false‑negative results. 2
Recent changes in antibiotic regimen (within the prior 24–72 h) markedly increase the risk of culture negativity. 8

Obtain blood cultures before any antibiotic administration or change whenever feasible. 5
Collect at least two sets (≈ 60 mL total) from different anatomical sites to improve detection. 11
In patients already receiving antibiotics, use culture bottles that contain antibiotic‑adsorbing media (e.g., BacT/Alert FAN, BACTEC Plus/F). 10

For patients on high‑dose meropenem with ongoing fever, consider temporarily holding antibiotics if the patient is clinically stable, recognizing that cultures may stay negative for weeks after such therapy. 3
Pursue alternative diagnostics—serology for fastidious organisms and PCR‑based assays—to identify pathogens missed by standard cultures. 6
Assess for non‑infectious causes of fever, especially when the overall clinical picture is improving. 7
In severely neutropenic individuals whose fever persists >3–5 days despite broad‑spectrum antibacterials, initiate empiric antifungal therapy. 7

Drawing blood cultures after initiating or altering broad‑spectrum antibiotics such as meropenem is the most critical error; it dramatically lowers yield and can produce weeks‑long culture negativity even when true bacteremia is present. 1